Collaboration between oncologists and pharmacists is crucial for optimizing value-based oncology care and overcoming access barriers to therapies and tests. Enhancing access to biomarker testing and ...

Keytruda's first approval by US FDA came in the year 2014 for advanced skin cancer. Now, the immunotherapy drug is being used ...

As the medical school landscape shifts in response to federal pressures and new demands in the healthcare space — such as technological advancements, AI and drug innovations — new physicians may be ...

GG1 prostate cancer can have heterogeneous outcomes, with some patients having intermediate- or high-risk disease, challenging the notion of GG1 as uniformly low-risk. Removing the cancer label for ...

A recent report reveals a concerning rise in cancer diagnoses in the UK, with one person diagnosed every 80 seconds. This ...